References
- Kahn JK, Rutherford BD, McConahay DR, et al. High-dose contrast agent administration during complex coronary angioplasty. Am Heart J 1990: 120(3): 533–6
- Phillips SJ, Spector M, Zeff RH, et al. Hematocrit changes after uncomplicated percutaneous transluminal coronary angioplasty. Am J Cardiol 1989: 64(14): 940
- Skillman JJ, Kim D, Baim DS. Vascular complications of percutaneous femoral cardiac interventions: incidence and operative repair. Arch Surg 1988: 123(10): 1207–12
- Kahn JK, Rutherford BD, McConahay DR, et al. Supported “high risk” coronary angioplasty using intraaortic balloon pump counterpulsation. J Am Coll Cardiol 1990: 15(4): 1151–5
- Cohen GI, Chan KL. Physical examination and echo Doppler study in the assessment of femoral arterial complications following cardiac catheterization. Cathet Cardiovasc Diagn 1990: 21(3): 137–43
- Schwartz L, Bourassa MG, Lesperance J, et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988: 318(26): 1714–9
- Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990: 336(8708): 129–33
- Squires RW, Gau GT, Miller TD, et al. Cardiovascular rehabilitation: status, 1990. Mayo Clin Proc 1990: 65(5): 731–55
- Fitzgerald ST, Becker DM, Celentano DD, et al. Return to work after percutaneous transluminal coronary angioplasty. Am J Cardiol 1989: 64(18): 1108–12
- Mabin TA, Holmes DR Jr, Smith HC, et al. Follow-up clinical results in patients undergoing percutaneous transluminal coronary angioplasty. Circulation 1985: 71(4): 754–60
- Forrester JS, Fishbein M, Helfant R, et al. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol 1991: 17(3): 758–69
- O'Keefe JH Jr, Hartzler GO. Restenosis after coronary angioplasty. J Inv Cardiol 1989: 1(2): 109–22
- Sahni R, Maniet AR, Voci G, et al. Prevention of restenosis by lovastatin after successful coronary angioplasty. Am Heart J 1991: 121(6 Pt 1): 1600–8
- Manyari DE, Knudtson M, Kloiber R, et al. Sequential thallium-201 myocardial perfusion studies after successful percutaneous transluminal coronary artery angioplasty: delayed resolution of exercise-induced scintigraphic abnormalities. Circulation 1988: 77(1): 86–95
- Hecht HS, Shaw RE, Chin HL, et al. Silent ischemia after coronary angioplasty: evaluation of restenosis and extent of ischemia in asymptomatic patients by tomographic thallium-201 exercise imaging and comparison with symptomatic patients. J Am Coll Cardiol 1991: 17(3): 670–7
- Aboul-Enein H, Bengston JR, Adams DB, et al. Effect of the degree of effort on exercise echocardiography for the detection of restenosis after coronary artery angioplasty. Am Heart J 1991: 122(2): 430–7
- Glazier JJ, Varricchione TR, Ryan TJ, et al. Outcome in patients with recurrent restenosis after percutaneous transluminal balloon angioplasty. Br Heart J 1989: 61(6): 485–8
- Webb JG, Myler RK, Shaw RE, et al. Bidirectional crossover and late outcome after coronary angioplasty and bypass surgery: 8 to 11 year follow-up. J Am Coll Cardiol 1990: 16(1): 57–65
- O'Keefe JH Jr, Rutherford BD, McConahay DR, et al. Multivessel coronary angioplasty from 1980 to 1989: procedural results and long-term outcome. J Am Coll Cardiol 1990: 16(5): 1097–102